Ribecca - A Phase 3b, Multi-Center, Open Label Study For Women With Estrogen Receptor Positive, Locally Advanced Or Metastatic Breast Cancer Treated With Ribociclib (Lee011) In Combination With Letrozole: Final Results

CANCER RESEARCH(2021)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要